dr. reddy's labs glp-1 receptor agonists weight management diabetes treatments Laboratories has entered the fast-growing therapy segment with the launch of its semaglutide generic, Obeda, for Type 2 in India's โน1,446 crore market. ๐๐๐๐ ๐๐ฎ๐ฅ๐ฅ ๐๐ซ๐ญ๐ข๐๐ฅ๐ ๐จ๐ง ๐จ๐ฎ๐ซ Dr Reddy's on 'Obeda' launch:
Pay in 4 interest-free payments of $6.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 9 - Aug 14


























